Major news about two hepatitis drugs | | |
Promising news about a potential new treatment for hepatitis B came last month at a scientific conference in Spain. Bepirovirsen, which is a GSK drug, led to a functional cure in nearly 20% of chronic hepatitis B patients treated for six months, the company said.
Anna Lok, MD, of the University of Michigan and advisor to the Hepatitis B Foundation, said the data “…represent a major step toward a functional cure for HBV infection, and bepirovirsen is an attractive option for selected patients.” You can read more here.
| | |
Chari Cohen, DrPH, MPH
President, Hepatitis B Foundation
| | |
Also last month, regulators approved Hepcludex as the first treatment in the U.S. for hepatitis D.
“Until now, there was very little that we could do to prevent cirrhosis and liver cancer for people living with hepatitis delta in the U.S.,” Hepatitis B Foundation president Chari Cohen, DrPH, MPH, said. You can read more here.
| | New translated hepatitis B birth dose fact sheets | The Hepatitis B Foundation has created a Hep B Birth Dose Media Toolkit highlighting the life-saving impact of the HBV vaccine for communities, healthcare providers and advocates. To support your outreach, we are offering new patient fact sheets in English, Spanish, Chinese and French. Visit our website to download the PDFs today to help raise awareness, encourage timely vaccination and protect the next generation. | | We’re now on TikTok! Follow us @hepbfoundation | | | | |
The Hepatitis B Foundation is officially on TikTok! We are taking our mission to a whole new platform to share health education, dispel common hepatitis B myths, highlight powerful patient stories and give you a behind-the-scenes look at our advocacy work.
Whether you're looking for quick public health facts or want to help us spread awareness to a younger global audience, we’d love to have your support.
👉 Follow @hepbfoundation on TikTok and join the conversation today!
| | Share your voice on the Foundation's quality-of-life survey | | | | |
The Hepatitis B Foundation is seeking participants for a new research study titled HepB PROACTive (Hepatitis B: Patient-Reported Outcomes, Adherence and Quality-of-Life Tracking).
The goal of this program is to better understand the daily experiences, treatment challenges and overall well-being of individuals living with chronic hepatitis B.
We're seeking adults age 18+ with hepatitis B living anywhere in the world.
| | Amplifying voices at New York City Hall | | |
In honor of Hepatitis Awareness Month, our storytelling manager, Michelle Liu, attended the 14th Annual HepFreeNYC Hepatitis Awareness Month Awareness event. Held on May 19 at City Hall, the event brought together public health leaders, city council members, healthcare providers and advocates.
A true highlight of the day was hearing from Binh, a dedicated #justB storyteller representing the Hepatitis B Foundation.
| | | Binh shared his personal journey focusing on the critical importance of testing, vaccination and stigma-free care. It was awesome to see many of the Foundation's NYC partners stand together make real impact. | | |
Foundation Public Health Team showcases
community partnerships at CDRD
| | |
Two of our public health team members, Stella Dlamini and Noah Trudeau, recently participated in Community-Driven Research Day (CDRD)! This collaborative initiative brings together researchers and community-based organizations across Pennsylvania to foster meaningful partnerships around community-identified research priorities. The theme was “Translating Community Questions into Impact.”
The Hepatitis B Foundation presented a poster highlighting our work to increase hepatitis B education, screening, and linkage to care through Hep B United Philadelphia (HBUP).
| | |
L-R: Noah Trudeau, MSPH
and Stella Dlamini, MPH
| | In addition, our team highlighted the ongoing HepB PROACTive study, which aims to better understand the experiences of individuals living with chronic hepatitis B globally. | | New training module: Funding the fight against hepatitis | | | | |
Securing resources is one of the biggest hurdles in the global effort to eliminate viral hepatitis. To help you navigate this complex landscape, the Hepatitis B Foundation has launched a new, free online course: Funding the Fight Against Hepatitis.
Whether you are an advocate, a health care professional or community organization, this course will equip you with the skills needed to secure funding, build powerful partnerships and advance liver health initiatives worldwide.
| | Download this new hepatitis B app today for free | | The newly available HepB & Me App is designed to support individuals living with chronic hepatitis Band their health care professionals in navigating the best care possible. | | | |
-
Smart medication reminders: Set automated alerts to ensure daily doses of antiviral therapies are never missed.
-
Health and lab tracking: Log routine lab results, viral load measurements to visualize treatment efficacy.
-
Clinical partnership pools: Organize health data into easy-to-read reports that can be shared with primary care providers.
| | New blog: Why your doctors need to work together | | | | |
Living with hepatitis B is a lifelong journey—and one that shouldn’t be walked alone.
Our latest post breaks down why a seamless partnership between your primary care doctor and a liver specialist is the ultimate game-changer for your health. From staying on top of routine labs to ensuring you never miss a critical liver cancer screening, teamwork truly saves lives. Please read the full blog here.
| | B Heppy Podcast: Viral hepatitis and MASH/MASLD | | In this episode, hosts Bright and Anousha sit down with Dr. Joseph Lim, Director of Clinical Hepatology at the Yale School of Medicine, for a conversation on the comorbid landscape of liver health. Together, they explore how viral hepatitis overlaps with MASH (Metabolic Dysfunction-Associated Steatohepatitis) and MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), and what this means for disease progression and patient care. Please listen to the podcast here. | | | | | Featured session: VCTE in liver disease staging and clinical care pathways | | This session is available in French here. | | |
Join Dr. Robert Gish, Medical Director for the Hepatitis B Foundation, for an insightful exploration into the pivotal role of Vibration-Controlled Transient Elastography (VCTE) in liver disease staging.
This session covers the practical application of VCTE in clinical care pathways for monitoring and surveillance—including current clinical evidence, guidelines, practical use cases and a live case demonstration.
| | | July 9
2 p.m. EDT | Webinar: Navigating hepatitis B care and the U.S. healthcare system for new communities | Register here. | | July 14
2 p.m. EDT | Webinar: Functional cure in hepatitis B: What does it mean for the U.S.? | Register here. | | July 28 | World Hepatitis Day, [media toolkit] | | Sept. 6
1 - 2:30 p.m. SGT | Community Forum at the 2026
International HBV Meeting, Singapore | | Sept. 6-10 | International HBV Meeting, Singapore | | | Journal article of the month |
Why does hepatitis B remain underprioritized? A view through lived experience
World Journal of Methodology | June 20, 2026 | [click here]
Ibrahim Y, Qureshi A, Jackson M, Zovich B, Freeland C, Flomo M, Alik K, Yakubov R,
Chen L-H, Yeboah P K, Cohen C
This article, co-authored by the Hepatitis B Foundation and members of our Community Advisory Board, explores the question of why hepatitis B remains underprioritized globally, "despite the availability of effective vaccines, diagnostics, and treatments." The authors explore challenges hindering progress towards hepatitis B elimination and lessons we can learn from other global diseases. The authors end with a "call to action for greater investment, cross-sector collaboration, integration of disease programs to improve efficiency, and inclusion of patient-reported outcomes in hepatitis B management and evaluation, to better support those living with hepatitis B."
| |
The Hepatitis B Foundation is a global nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B. Our commitment includes funding focused research, promoting disease awareness, supporting immunization and treatment initiatives, and serving as the primary source of information for patients and their families, the medical and scientific community and the general public. | | Learn more about our research and education programs at www.hepb.org | | | | | | |